SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Mylan Labs
MYL 15.860.0%Nov 19 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Lawrence who wrote (352)7/25/1998 12:12:00 AM
From: Druggist  Read Replies (1) of 384
 
Still seeing a bunch of Mylan products being added to Medicine Shoppe contract.... also, Schein pharmaceutical (SHP) bears taking a close look also... was an IPO about 3-4 months ago, went from 21 to now about 30... was just upgraded to a strong buy, with a 12-18 month price target of 40 + ...

I see a VERY bright outlook for ALL the generic companies... in the next 3 years, we have a plethora of branded drugs coming off patent.. can you say Mevacor, Prozac, Prilosec, etc.. etc ????

Druggist
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext